TM Editors Note: This article discusses one or more penny stocks and/or microcaps. Such stocks are readily manipulated; do your own careful due diligence. 

The munKNEE Pure-Play Pot Stock Index is down 3.5% so far this week after having taken a rest last week (+0.56%) following a 25.6% in the first 2 weeks of the month with 25 of the 30 constituents in the Index declining. Details are as follows:

Index Performance

The Canadian Licensed Producer (LP) Category has gone down 5.0% so far week with all but one of the 9 stocks within the category declining and 2 doing so by 5% or more, namely:

1. Canopy Growth (CGC): -7.8% to $35.61/share
2. Cronos (CRON): -7.2% to $11.41/share

with Aurora, Organigram, and Tilray declining so far this week by 4.7%, 4.5%, and 4.2%, respectively.  Valens (VLNCF) is up 1.4% so far this week. The remaining 3 stocks are down less than 4% for the week.

The U.S. Multi-State Operator (MSOs) Category is down 2.7%  so far this week with only 5 of the 21 constituents in the category advancing of which only Jushi (JUSHF) is up (6.0%) in excess of 5% and 7 declining in excess of 5%, as follows:

1. Indus (INDXF): -12.6% to $1.52/share
2. Medicine Man (SHWZ): -10.5% to $2.55/share
3. Harvest Health (HRVSF): -10.1% to $4.00/share
4. Charlotte's Web (CWBHF): -8.8% to $5.20/share
5. C21 Investments (CXXIF): -6.4% to $1.62/share
6. IM Cannabis (IMCNF): -5.9% to $7.70/share
7. Green Thumb (GTBIF): -5.1% to $34.89/share

The remaining 13 constituents are up or down by less than 5% so far this week.

Further details regarding the equal-weighted munKNEE Pure-Play Pot Stock Index are as follows:

• Only 30 stocks qualify for inclusion in the Index out of a total of over 225 (pure-play and ancillary) trading on North American exchanges.
• The average market capitalization of the 30 constituents is US$1.5B, as follows:
  • 10 have market caps ranging between $1.0B and $10.0B;
  • 5 have market caps between $500M and $999M;
  • 12 have market caps between $100M and $499M and
  • 3 have market caps of less than $100M.